References
- FongDTHongYChanLKYungPSChanKMA systematic review on ankle injury and ankle sprain in sportsSports Med2007371739417190537
- SimonTDBublitzCHambidgeSJEmergency department visits among pediatric patients for sports-related injury: basic epidemiology and impact of race/ethnicity and insurance statusPediatr Emerg Care200622530931516714957
- SoboroffSHPappiusEMKomaroffALBenefits, risks, and costs of alternative approaches to the evaluation and treatment of severe ankle sprainClin Orthop Relat Res19841831601686421526
- WolfeMWUhlTLMattacolaCGMcCluskeyLCManagement of ankle sprainsAm Fam Physician20016319310411195774
- MoranMDouble-blind comparison of diclofenac potassium, ibuprofen and placebo in the treatment of ankle sprainsJ Int Med Res19911921211301864448
- DiazJACuervoCValderramaAMKohlelJValdecoxib provides effective pain relief following acute ankle sprainJ Int Med Res200634545646717133774
- LanasACyclo-oxygenase-1/cyclo-oxygenase-2 non selective non-steroidal anti-inflammatory drugs: epidemiology of gastrointestinal eventsDig Liver Dis200133Suppl 2S29S3411827360
- MooreRADerrySMcQuayHJCyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular riskBMC Musculoskelet Disord200787317683540
- FriesJFWilliamsCABlochDAMichelBANonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor modelsAm J Med19919132132221892140
- WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal antiinflammatory drugsN Engl J Med1999340241888189910369853
- KearneyPMBaigentCGodwinJDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ200633275531302130816740558
- SolomonSDMcMurrayJJPfefferMAAdenoma Prevention with Celecoxib (APC) Study InvestigatorsCardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionN Engl J Med2005352111071108015713944
- SopenaFLanasAHow to advise aspirin use in patients who need NSAIDsCurr Pharm Dis2007132222482260
- CaponeMLSciulliMGTacconelliSPharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjectsJ Am Coll Cardiol20054581295130115837265
- Catella-LawsonFReillyMPKapoorSCCyclooxygenase inhibitors and the antiplatelet effects of aspirinN Engl J Med2001345251809181711752357
- OuelletMRiendeauDPercivalMDA high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirinProc Natl Acad Sci U S A20019825145831458811717412
- Food and Drug AdminstrationInformation for Healthcare Professionals: Concomitant Use of Ibuprofen and Aspirin2006http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm125222.htmAccessed January 13, 2011
- RendaGTacconelliSCaponeMLCelecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseClin Pharmacol Ther200680326427416952493
- PetersenBRovatiSDiclofenac epolamine (Flector) patch: evidence for topical activityClin Drug Investig200929119
- JoussellinEFlector Tissugel® dans le traitement des entorses douloureuses de la cheville [Flector Tissugel® in the treatment of painful ankle sprain]J Traumatol Sport2003201S5–1S9
- RowbothamMCGalerBSBlockJAFlector Tissugel®: efficacité et tolérance dans le traitement des microtraumatismes sportifs. Données d’une étude contrôlée conduite aux Etats-Unis [Flector Tissugel®: efficacy and safety in the treatment of minor sports injuries. Data from a controlled trial in the United States]J Traumatol Sport2003201S15–11S20
- SaillantGÉtude comparant l’efficacité et la tolérance de Flector Tissugel® à celles d’un placebo dans le traitement des entorses bénignes de la cheville. [Study comparing the efficacy and tolerance of Flector Tissugel® to that of a placebo in the treatment of benign ankle sprains]Medicine du Sport19987215
- BrühlmannPde VathaireFDreiserRLMichelBAShort-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studiesCurr Med Res Opin200622122429243817257457
- ArroyoJFVathaireFMautoneGA study of the short-term efficacy of Flector EP Tissugel (Diclofenac epolamine) for the local treatment of abarticular pathologies of the shoulder and the knee in elderly subjects. [Clinical Study Report]. Data on fileKing Pharmaceuticals®, Inc.2002
- JenourePSegesserBLuhtiUGremionGA trial with diclofenac HEP plaster as topical treatment in minor sport injuriesDrugs Exp Clin Res19931931251318112201
- RainsfordKDKeanWFEhrlichGEReview of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamineCurr Med Res Opin200824102967299218814824
- GiamberadionoMEffects of topical diclofenac on pain and periarticular pain sensitivity in patients with osteoarthritis of the kneeFlector Tissugel®: Diclofenac Epolamine Plaster Product MonographPambio-Noranco, SwitserlandInstitut Biochimique SA72005 Clinical Efficacy of Flector EP Tissuegel20054951
- MooreRATramerMRCarrollDWiffenPJMcQuayHJQuantitative systematic review of topically applied non-steroidal anti-inflammatory drugsBMJ199831671283333389487165
- WoberWComparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulideRheumatology (Oxford)199938Suppl 1333810369404
- KruegerKLinoLDoreRGastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II)Ann Rheum Dis200867331532217965424